The Rare2030 Foresight Study - building a better future for people living with a rare disease
The Rare2030 Foresight Study continues! After one year of reflection and with a nearly 200-person-strong Panel of Experts, the study has reached its third phase.
|EUROPEAN CONFERENCE ON RARE DISEASES & ORPHAN PRODUCTS|
|EURORDIS BLACK PEARL AWARDS|
|RARE BAROMETER VOICES|
|WHAT'S NEW AT EURORDIS?|
|PATIENTS ADVANCING RESEARCH|
This publication (or activity) has been funded with support from the European Union's Health Programme. This material only reflects the views of the author, and funders cannot be held responsible for any use which may be made of the information contained herein.